| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $26.05 ▲ +1.41% | Yesterday | $25.54 ▼ -0.59% | Tomorrow's Maze Therapeutics Inc. Common Stock (MAZE) setup is anchored to $25.69 and targets $26.05 (+1.41%). The near-term read is upside; watch $26.46 / $24.92 because daily realized volatility is about 7.29%. |
Tomorrow's Maze Therapeutics Inc. Common Stock (MAZE) setup is anchored to $25.69 and targets $26.05 (+1.41%). The near-term read is upside; watch $26.46 / $24.92 because daily realized volatility is about 7.29%. | ||||
| Week | $26.82 ▲ +4.40% | Last Week | $25.22 ▼ -1.85% | The 7-day Maze Therapeutics Inc. Common Stock model moves from $25.22 to $26.82 (+4.40%). It gives upside momentum context for this stock, so breaks around $26.46 / $24.92 matter more than a single tick. |
The 7-day Maze Therapeutics Inc. Common Stock model moves from $25.22 to $26.82 (+4.40%). It gives upside momentum context for this stock, so breaks around $26.46 / $24.92 matter more than a single tick. | ||||
| Month | $28.10 ▲ +9.37% | Last Month | $24.68 ▼ -3.94% | The 1-month Maze Therapeutics Inc. Common Stock target is $28.10 (+9.37%), compared with the live reference near $25.69. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Maze Therapeutics Inc. Common Stock target is $28.10 (+9.37%), compared with the live reference near $25.69. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $30.01 ▲ +16.82% | Last Year | $23.87 ▼ -7.07% | The 1-year Maze Therapeutics Inc. Common Stock scenario points to $30.01 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Maze Therapeutics Inc. Common Stock scenario points to $30.01 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $34.50 ▲ +34.29% | 5 Years Ago | $21.99 ▼ -14.40% | The 5-year Maze Therapeutics Inc. Common Stock view is $34.50 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Maze Therapeutics Inc. Common Stock view is $34.50 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $25.69 | Mid |
| Daily Change | -4.29% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $25.69 | Daily Change | -4.29% |
| Market Cap | $1.28B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.